To abolish the pro-tumor effects of IL-33/ST2L signal in TME, we generated IL-33-neutralizing (α-IL-33) and ST2L-neutralizing antibody (α-ST2L) (Supplementary Fig. S3A, B) and examined their effects on macrophage polarization. The gene discussed is IL33; the disease is neoplasm.